Data as of Jul 21
| +0.02 / +1.35%|
The 1 analysts offering 12-month price forecasts for TapImmune Inc have a median target of 6.97, with a high estimate of 6.97 and a low estimate of 6.97. The median estimate represents a +364.67% increase from the last price of 1.50.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.